BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37094850)

  • 61. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.
    Yan B; Liu L; Zhao Y; Xiu LJ; Sun DZ; Liu X; Lu Y; Shi J; Zhang YC; Li YJ; Wang XW; Zhou YQ; Feng SH; Lv C; Wei PK; Qin ZF
    World J Gastroenterol; 2014 Sep; 20(36):13105-18. PubMed ID: 25278704
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
    Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Baicalein modulates the radiosensitivity of cervical cancer cells in vitro via miR-183 and the JAK2/STAT3 signaling pathway.
    Lei H; Shi J; Teng Y; Song C; Zou L; Ye F; Zhang H
    Adv Clin Exp Med; 2021 Jul; 30(7):727-736. PubMed ID: 34118143
    [TBL] [Abstract][Full Text] [Related]  

  • 64. α-Mangostin attenuates stemness and enhances cisplatin-induced cell death in cervical cancer stem-like cells through induction of mitochondrial-mediated apoptosis.
    Chien HJ; Ying TH; Hsieh SC; Lin CL; Yu YL; Kao SH; Hsieh YH
    J Cell Physiol; 2020 Jul; 235(7-8):5590-5601. PubMed ID: 31960449
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ShRNA targeting Bmi-1 sensitizes CD44⁺ nasopharyngeal cancer stem-like cells to radiotherapy.
    Xu XH; Liu XY; Su J; Li DJ; Huang Q; Lu MQ; Yi F; Ren JH; Chen WH
    Oncol Rep; 2014 Aug; 32(2):764-70. PubMed ID: 24927072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects and mechanisms of anti-CD44 monoclonal antibody A3D8 on proliferation and apoptosis of sphere-forming cells with stemness from human ovarian cancer.
    Du YR; Chen Y; Gao Y; Niu XL; Li YJ; Deng WM
    Int J Gynecol Cancer; 2013 Oct; 23(8):1367-75. PubMed ID: 24257550
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RNF183 Promotes Colon Cancer Cell Stemness through Fatty Acid Oxidation.
    Song Y; Li X; Wu H; Xu Y; Jin D; Ping S; Jia J; Han C
    Nutr Cancer; 2024; 76(2):215-225. PubMed ID: 38044546
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells.
    Mustofa ; Satriyo PB; Suma AAT; Waskitha SSW; Wahyuningsih TD; Sholikhah EN
    Drug Des Devel Ther; 2022; 16():2325-2339. PubMed ID: 35899233
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel small molecule XPO1/CRM1 inhibitors induce nuclear accumulation of TP53, phosphorylated MAPK and apoptosis in human melanoma cells.
    Yang J; Bill MA; Young GS; La Perle K; Landesman Y; Shacham S; Kauffman M; Senapedis W; Kashyap T; Saint-Martin JR; Kendra K; Lesinski GB
    PLoS One; 2014; 9(7):e102983. PubMed ID: 25057921
    [TBL] [Abstract][Full Text] [Related]  

  • 70. XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).
    Gravina GL; Tortoreto M; Mancini A; Addis A; Di Cesare E; Lenzi A; Landesman Y; McCauley D; Kauffman M; Shacham S; Zaffaroni N; Festuccia C
    J Hematol Oncol; 2014 Oct; 7():46. PubMed ID: 25284315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors.
    Turner JG; Dawson JL; Grant S; Shain KH; Dalton WS; Dai Y; Meads M; Baz R; Kauffman M; Shacham S; Sullivan DM
    J Hematol Oncol; 2016 Aug; 9(1):73. PubMed ID: 27557643
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
    Zhang X; Wang M; Zhang Y; Yang J; Duan W
    Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.
    Subhash VV; Yeo MS; Wang L; Tan SH; Wong FY; Thuya WL; Tan WL; Peethala PC; Soe MY; Tan DSP; Padmanabhan N; Baloglu E; Shacham S; Tan P; Koeffler HP; Yong WP
    Sci Rep; 2018 Aug; 8(1):12248. PubMed ID: 30115935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance.
    Liu D; Ke J; Liu Y; Rao H; Tang Z; Liu Y; Zhang Z; You L; Luo X; Sun Z; He Z; Li F; Qiu Z; Hu J; Mbadhi MN; Tang J; Wu F; Li S
    Mol Carcinog; 2021 Dec; 60(12):813-825. PubMed ID: 34499772
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The role and mechanism of tumor metastasis-associated gene 1 in radiosensitivity of HeLa cells].
    Sun FZ; Wang JS; Li CX; Wang T; Zhang JY; Zhou YT; Wang HJ; Qian HL
    Zhonghua Zhong Liu Za Zhi; 2022 Sep; 44(9):962-967. PubMed ID: 36164698
    [No Abstract]   [Full Text] [Related]  

  • 76. RBM5-AS1 promotes radioresistance in medulloblastoma through stabilization of SIRT6 protein.
    Zhu C; Li K; Jiang M; Chen S
    Acta Neuropathol Commun; 2021 Jul; 9(1):123. PubMed ID: 34225779
    [TBL] [Abstract][Full Text] [Related]  

  • 77. USP14 promotes the malignant progression and ibrutinib resistance of mantle cell lymphoma by stabilizing XPO1.
    Zhang Y; Lu P; Jin S; Zhang J; Zhou Y
    Int J Med Sci; 2023; 20(5):616-626. PubMed ID: 37082728
    [No Abstract]   [Full Text] [Related]  

  • 78. [METTL14 promotes the proliferation and migration of cervical cancer cells by up-regulating m
    Hu C; Liu T; Xu Y; Han C; Yang S; Yang K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Feb; 38(2):131-137. PubMed ID: 35356881
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
    Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
    Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
    [No Abstract]   [Full Text] [Related]  

  • 80. The role of ATM and 53BP1 as predictive markers in cervical cancer.
    Roossink F; Wieringa HW; Noordhuis MG; ten Hoor KA; Kok M; Slagter-Menkema L; Hollema H; de Bock GH; Pras E; de Vries EG; de Jong S; van der Zee AG; Schuuring E; Wisman GB; van Vugt MA
    Int J Cancer; 2012 Nov; 131(9):2056-66. PubMed ID: 22323184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.